Patients with lymph node metastasis exhibited higher DSG2 expression than patients without lymph node metastasis (0.113 ± 0.087 vs 0.053 ± 0.034, p = 0.014). The gene discussed is DSG2; the disease is metastatic malignant neoplasm in the lymph nodes.